ONZ team boosted
Kim Down has joined the Ophthalmology New Zealand (ONZ) team as executive assistant, supporting CEO Moira McInerney.
Staff reporters2 min read
Advertisement
Kim Down has joined the Ophthalmology New Zealand (ONZ) team as executive assistant, supporting CEO Moira McInerney.
A South Auckland pilot programme found community pharmacists, working with general practice nurses, significantly lowered and sustained blood glucose levels in patients with type 2 diabetes (T2D).
US researchers have launched a national clinical trial to test whether low-dose atropine eye drops can prevent the development of myopia in children.
With no frames in sight, new practice Illume Eye Care in Ponsonby, Auckland, is open for patients seeking anything from a comprehensive eye exam to specialised care in myopia management, contact lenses and speciality contact lenses, dry eye disease and ocular surface disease management, keratoconus
EssilorLuxottica boosted its myopia portfolio at the recent China International Import Expo in Shanghai, launching Essilor Stellest 2.0 in Greater China, with other key markets to follow in 2026.
University of Auckland medical student Robin Yang is the proud recipient of this year’s Gordon Sanderson Scholarship.
Research from Aspect’s Research Centre for Autism Practice (ARCAP) has identified significant barriers autistic people face when accessing eyecare in Australia and New Zealand.
Topcon Healthcare has signed a definitive agreement to acquire New Zealand-founded AI health-technology company Toku Eyes, now based in San Diego. The acquisition is part of the integration of Toku’s
In a bid to strengthen the pharmacy workforce and remove “unnecessary” regulation, parliament has passed a bill that will scrap one of three pharmacy ownership rules, allowing prescribers to become pharmacy owners.
Corneal Lens Corporation (CLC) is bringing the benefits of time-tested silk proteins in eye-drop form with the launch of Evolve Silk, a preservative-free drop designed to repair the corneal epithelium.
A Canterbury man with neovascular age-related macular degeneration (nAMD) permanently lost sight in his right eye after a delayed follow-up for anti-VEGF injections, according to a Health and Disability Commissioner (HDC) decision. The delay followed the patient, previously stabilised on aflibercept
The Eye Health National Clinical Network is advancing work on a nationally consistent model for optometry-led postoperative care following cataract surgery, with Health New Zealand (HNZ) asking it to push ahead with work on procurement and funding models.